Rafael Bejar is an Oncology physician affiliated with UC San Diego Health System. OpenAlex indexes 272 publications with 15,809 citations (h-index 43); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3855 Health Sciences Dr
Mc 0820
La Jolla, CA 920930820
Telephone
858-534-5204Registry record last updated 28 Feb 2013.
Clinical trials
- A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
Sponsor: Aptose Biosciences Inc.
- A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Sponsor: Aptose Biosciences Inc.
- Collection of Samples From Patients With MDS
Sponsor: PersImmune, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Epizyme, Inc.Program year20252 payments
- Geron CorporationProgram year20251 payment
- ABBVIE INC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 1998–2016 per NIH RePORTER. The latest:
- Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
University of California, San Diego
FY2016$157,442K08DK091360 - Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
University of California, San Diego
FY2015$157,442K08DK091360 - Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
University of California, San Diego
FY2014$157,442K08DK091360
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Lowy, MD
UC San Diego Health System
Roger Spragg, MD
UC San Diego Health System
Zea Borok, MD
UC San Diego Health System
Patricia Thistlethwaite, MD/PHD
UC San Diego Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”